Balanced news tone
News Sentiment
CDXS sentiment intelligence
Codexis Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
54 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-1.6% over one week, +1.3% over four weeks, trend active, and near fair-value range.
Price to earnings forward of Codexis, Inc. – NASDAQ:CDXS
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Earnings
78/100 classification
One-week reaction
-1.6%
Price digesting
Trend fit
Trend active
1.3% over four weeks
Fair value
-11.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
12
Neutral
38
Negative
4
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Motley Fool
Direct company coverage
Codexis (CDXS) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 19:32
- Source
- Motley Fool
Moby
Direct company coverage
Codexis, Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 12:30
- Source
- Moby
MarketBeat
Direct company coverage
Codexis Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 21:39
- Source
- MarketBeat
Associated Press
Direct company coverage
Codexis: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 21:34
- Source
- Associated Press
Market source
Direct company coverage
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Codexis Reports First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- GlobeNewswire
Stock Titan
Direct company coverage
Codexis says it has cash through 2027 as siRNA plans advance
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 07 May 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Codexis sets May 7 earnings call, business update at 4:30 p.m. ET
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Apr 2026 07:00
- Source
- Stock Titan
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Analyst Sentiment Unchanged After Codexis (CDXS) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Mar 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 15 Mar 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 14 Mar 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Codexis (CDXS) Is Up 30.9% After Returning To Q4 Profitability And Issuing 2026 Revenue Guidance
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Mar 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- simplywall.st
Seeking Alpha
Direct company coverage
Codexis stock rises after Q4 beat, outlook (CDXS:NASDAQ)
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 12 Mar 2026 07:00
- Source
- Seeking Alpha
Seeking Alpha
Direct company coverage
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform (NASDAQ:CDXS)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Mar 2026 07:00
- Source
- Seeking Alpha
simplywall.st
Direct company coverage
Positive Sentiment Still Eludes Codexis, Inc. (NASDAQ:CDXS) Following 29% Share Price Slump
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Analysts Expect Breakeven For Codexis, Inc. (NASDAQ:CDXS) Before Long
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Feb 2026 08:00
- Source
- Market source